Helping Cancer Patients with Chronic Pain
Creating Ethical Shareholder Value

Business Strategy

Market potential, Real World Evidence & Changing Perspectives.

Helping Cancer Patients with Chronic Pain

CBD Science Group PLC has identified this unmet medical need and have initiated Real World Evidence (RWE) clinical trials.

Creating Shareholder Value

Every 1000 patients treated has the potential to generate £3.6 million in annual revenue for CBD Science Group PLC.  Comparable companies are trading at 10 to 40 times revenue.

Market Potential


Why Real-World Evidence?

Patient Solutions

Reimbursement Decisions

Regulatory Decisions

Changing Perspectives

Too often UK patients are self-medicating, with illegal cannabis-based products simply the pathway to a legal, medical-cannabis prescription is so unclear and inaccessible. This must change for those in need.